Operating Margin of Ultragenyx Pharmaceutical Inc. from 31 Dec 2016 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Ultragenyx Pharmaceutical Inc. quarterly and annual Operating Margin in % history and change rate from 31 Dec 2016 to 31 Dec 2025.
  • Ultragenyx Pharmaceutical Inc. Operating Margin for the quarter ending 31 Dec 2025 was -79%, a 17% increase year-over-year.
  • Ultragenyx Pharmaceutical Inc. annual Operating Margin for 2025 was -79%, a 17% increase from 2024.
  • Ultragenyx Pharmaceutical Inc. annual Operating Margin for 2024 was -96%, a 27% increase from 2023.
  • Ultragenyx Pharmaceutical Inc. annual Operating Margin for 2023 was -131%, a 27% increase from 2022.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

Ultragenyx Pharmaceutical Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2025 -79% +16% +17% 01 Oct 2025 31 Dec 2025
Q3 2025 -86% +16% +16% 01 Jul 2025 30 Sep 2025
Q2 2025 -83% +31% +27% 01 Apr 2025 30 Jun 2025
Q1 2025 -87% +44% +34% 01 Jan 2025 31 Mar 2025
Q4 2024 -96% +35% +27% 01 Oct 2024 31 Dec 2024
Q3 2024 -102% +42% +29% 01 Jul 2024 30 Sep 2024
Q2 2024 -114% +53% +32% 01 Apr 2024 30 Jun 2024
Q1 2024 -131% +42% +24% 01 Jan 2024 31 Mar 2024
Q4 2023 -131% +48% +27% 01 Oct 2023 31 Dec 2023
Q3 2023 -145% +32% +18% 01 Jul 2023 30 Sep 2023
Q2 2023 -167% -26% -19% 01 Apr 2023 30 Jun 2023
Q1 2023 -174% -50% -40% 01 Jan 2023 31 Mar 2023
Q4 2022 -179% -70% -64% 01 Oct 2022 31 Dec 2022
Q3 2022 -176% -72% -69% 01 Jul 2022 30 Sep 2022
Q2 2022 -141% -47% -51% 01 Apr 2022 30 Jun 2022
Q1 2022 -124% -29% -31% 01 Jan 2022 31 Mar 2022
Q4 2021 -109% +13% +11% 01 Oct 2021 31 Dec 2021
Q3 2021 -104% +48% +32% 01 Jul 2021 30 Sep 2021
Q2 2021 -93% +155% +62% 01 Apr 2021 30 Jun 2021
Q1 2021 -95% +271% +74% 01 Jan 2021 31 Mar 2021
Q4 2020 -122% +287% +70% 01 Oct 2020 31 Dec 2020
Q3 2020 -153% +345% +69% 01 Jul 2020 30 Sep 2020
Q2 2020 -249% +308% +55% 01 Apr 2020 30 Jun 2020
Q1 2020 -366% +268% +42% 01 Jan 2020 31 Mar 2020
Q4 2019 -409% +312% +43% 01 Oct 2019 31 Dec 2019
Q3 2019 -498% +506% +50% 01 Jul 2019 30 Sep 2019
Q2 2019 -557% +869% +61% 01 Apr 2019 30 Jun 2019
Q1 2019 -634% 01 Jan 2019 31 Mar 2019
Q4 2018 -721% 01 Oct 2018 31 Dec 2018
Q3 2018 -1004% 01 Jul 2018 30 Sep 2018
Q2 2018 -1426% 01 Apr 2018 30 Jun 2018

Ultragenyx Pharmaceutical Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2025 -79% +16% +17% 01 Jan 2025 31 Dec 2025
2024 -96% +35% +27% 01 Jan 2024 31 Dec 2024
2023 -131% +48% +27% 01 Jan 2023 31 Dec 2023
2022 -179% -70% -64% 01 Jan 2022 31 Dec 2022
2021 -109% +13% +11% 01 Jan 2021 31 Dec 2021
2020 -122% +287% +70% 01 Jan 2020 31 Dec 2020
2019 -409% +312% +43% 01 Jan 2019 31 Dec 2019
2018 -721% +11872% +94% 01 Jan 2018 31 Dec 2018
2017 -12593% +173878% +93% 01 Jan 2017 31 Dec 2017
2016 -186471% 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.